Publications by authors named "Raygene Martier"

Claim this Profile
G
Gene Therapy for Neurodegenerative Diseases: Slowing Down the Ticking Clock.
Raygene Martier, Pavlina Konstantinova

Front Neurosci· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AAV5-miHTT Lowers Huntingtin mRNA and Protein without Off-Target Effects in Patient-Derived Neuronal Cultures and Astrocytes.
Sonay Keskin, Cynthia C Brouwers, Marina Sogorb-Gonzalez, Raygene Martier, Josse A Depla

Mol Ther Methods Clin Dev· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an AAV-Based MicroRNA Gene Therapy to Treat Machado-Joseph Disease.
Raygene Martier, Marina Sogorb-Gonzalez, Janice Stricker-Shaver, Jeannette Hübener-Schmid, Sonay Keskin

Mol Ther Methods Clin Dev· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting RNA-Mediated Toxicity in C9orf72 ALS and/or FTD by RNAi-Based Gene Therapy.
Raygene Martier, Jolanda M Liefhebber, Ana García-Osta, Jana Miniarikova, Mar Cuadrado-Tejedor

Mol Ther Nucleic Acids· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In-Depth Characterization of a Mifepristone-Regulated Expression System for AAV5-Mediated Gene Therapy in the Liver.
Jolanda M Liefhebber, Raygene Martier, Tom Van der Zon, Sonay Keskin, Angelina Huseinovic

Mol Ther Methods Clin Dev· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial MicroRNAs Targeting C9orf72 Can Reduce Accumulation of Intra-nuclear Transcripts in ALS and FTD Patients.
Raygene Martier, Jolanda M Liefhebber, Jana Miniarikova, Tom van der Zon, Jolanda Snapper

Mol Ther Nucleic Acids· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, Characterization, and Lead Selection of Therapeutic miRNAs Targeting Huntingtin for Development of Gene Therapy for Huntington's Disease.
Jana Miniarikova, Ilaria Zanella, Angelina Huseinovic, Tom van der Zon, Evelyn Hanemaaijer, Raygene Martier

Mol Ther Nucleic Acids· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation-induced cytidine deaminase induces reproducible DNA breaks at many non-Ig Loci in activated B cells.
Ori Staszewski, Richard E Baker, Anna J Ucher, Raygene Martier, Janet Stavnezer

Mol Cell· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis